New diuretic TORIKARD tablets 5 mg and 10 mg will be launched on the Ukrainian market in the near future.
In the near future, a new product of the company Ananta Medicare LTD. - TORIKARD tablets 5 mg and 10 mg №30 will be launched on the Ukrainian market.
The medicinal product was registered by the Order of the Ministry of Health №130 dated February 24, 2016The active substance of the medicinal product TORIKARD is torasemide. It belongs to the category of diuretics, high-level "loop" diuretics.Diuretics are substances that increase the excretion of urine and reduce the liquid content in the tissues and serous cavities of the body. Increased urination is connected with their specific effect on the kidneys (inhibition of the reabsorption of sodium ions in the renal tubules, which is accompanied by the water reabsorption decrease. The increase of glomerular filtration plays significantly smaller role.
The most powerful of existing diuretics are the "loop" diuretics. By the chemical structure they are derivatives of dichlorophenoxyacetic acid and sulfamoylanthranilic acid. The loop diuretics act throughout the ascending portion of the nephron loop (Henle's loop), and inhibit sharply the reabsorption of sodium and chloride ions; also the excretion of potassium ions is enhanced.
Loop diuretics are used for the treatment of hypertension and chronic heart failure. By increasing urine output, they reduce the circulating blood volume, so the venous return to the heart and the load on the myocardium reduce the congestion in the lungs.Torasemide is a loop diuretic; at low doses used for antihypertensive treatment, it has mild diuretic and saluretic actions. At higher doses, torasemide causes increased diuresis, which is dose-dependent. In 2-3 hours after oral administration Torasemide shows maximum diuretic activity, which remains constant for almost 12 hours.
TORIKARD is recommended for use in essential hypertension as monotherapy or in combination therapy with other antihypertensive agents.It is used to treat edema caused by chronic heart failure, kidney or liver disease.The product portfolio of the company Ananta Medicare LTD. contains an extensive list of cardiac medications. The company maintains an active information work among cardiologists. The new medicinal product TORIKARD will help to prevent hypertension and chronic heart failure.